Synchron
PrivateLast Round
Series D
Nov 6, 2025
Est. Valuation
$1B
Total Funding Raised
$325M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Synchron is a neurotechnology company that develops an implantable, minimally invasive brain-computer interface designed to interpret brain signals for treating conditions like paralysis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Medical AI, Health IoT
Business Model
B2B2C
Customer Profile
Hardware Sales, Government Contracts, Hardware + Subscription, Services & Consulting
AI Layer
Infrastructure
Keywords
Price History
Caplight MarketPrice™ estimate for Synchron, published with a 90-day delay.
Caplight MarketPrice™
$44.90
per share, as of June 2026
+21.1%
9-month change
Caplight MarketPrice™ is an estimate of private secondary market pricing, shown here on a delayed basis for illustrative purposes only. It may be incomplete, is subject to change, and may not be relied upon for any purpose or considered investment advice.
Synchron Comparables
Compare Synchron with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Precision Neuroscience | 86% | |
| Neuralink | 86% | |
| Paradromics | 82% |
Synchron Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Nov 6, 2025 | ||||
| Series C | Dec 15, 2022 | ||||
| Series B | Jun 3, 2021 | ||||
| Series A | Apr 4, 2017 |
Synchron Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forepont Capital Partners | Series B, Series C |
| Greenoaks Capital Partners | Series C |
| Khosla Ventures | Series C, Series D, Series B |
| U.S. Department of Defense | Series A |
| ARCH Venture Partners | Series D |
| Bezos Expeditions | Series C, Series D |
| re.Mind Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2026
Company scales to approximately 100 employees.
- May 3, 2026
Integration with Apple disclosed in job posting.
Synchron Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Synchron's valuation, stock price, and market status.
Is Synchron a public or private company?
Synchron is a private company.
What is the current stock price of Synchron?
Synchron is a private company with no public stock price. Caplight tracks Synchron's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Synchron worth (valuation)?
Valuation information for Synchron is not publicly available.
Can I buy Synchron stock?
Synchron shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Synchron's last funding round?
Synchron's most recent funding round was Series D on November 6, 2025.
Who are the main investors in Synchron?
Key investors in Synchron include Khosla Ventures, ARCH Venture Partners, NeuroTechnology Investors, Double Point Ventures.
Will Synchron IPO soon?
No public IPO plans have been announced for Synchron.
How can I track Synchron secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Synchron's secondary market activity and sign up for updates.